title: GISSI-2: mortality plus extensive left-ventricular damage as "end-point".
authors.forename: C
authors.initials: C
authors.lastname: De Vita
authors.forename: M G
authors.initials: MG
authors.lastname: Franzosi
authors.forename: E
authors.initials: E
authors.lastname: Geraci
authors.forename: A P
authors.initials: AP
authors.lastname: Maggioni
authors.forename: F
authors.initials: F
authors.lastname: Mauri
authors.forename: G
authors.initials: G
authors.lastname: Mezzanotte
authors.forename: L
authors.initials: L
authors.lastname: Tavazzi
authors.forename: G
authors.initials: G
authors.lastname: Tognoni
authors.forename: A
authors.initials: A
authors.lastname: Volpi
mesh_terms: D000465:Algorithms; D006352:Heart Ventricles / Q000293:injuries; D006801:Humans; D007558:Italy; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D013300:Streptokinase / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D013300:Streptokinase; D010959:Tissue Plasminogen Activator